Sickle cell disease center marketing: emergency wording, pain pages, teen transition forms and drug maker support

A sickle cell center is chosen by people who have lived with the disease for years and know what good care feels like. A parent whose newborn screening came back with a follow-up call wants to know who will see the baby. A teenager who has been seen at a children’s hospital all their life needs an adult team before the pediatric one lets go. An adult who has waited hours for pain care wants to know whether this clinic will listen and what to do at two in the morning. The center may be a hospital program, a hematology practice with a sickle cell clinic, a day hospital for pain crises or a community health center with a dedicated team. This guide covers what the federal patient pages say, the emergency wording each page needs, how to write about pain without stigma, treatment pages that stay current, newborn screening and trait, the forms and consent questions that come with the move from pediatric to adult care, and money from drug makers and referral partners.

Eight related topics have their own guides and are not repeated here. “Cure”, transplant and gene therapy wording, respectful language and the sensitive ad categories for sickle cell disease are covered in our guide to hematology practice marketing. Parents, personal representatives and children’s privacy in general are covered in our guide to pediatric practice marketing. Opioid and pain treatment claims are covered in our guide to pain management clinic marketing. Infused medicines, copay coupons and drug names in Google Ads are covered in our guide to infusion center marketing. Transplant programs are covered in our guide to transplant center marketing, study recruitment in our guide to clinical trial recruitment ads, carrier and gene tests in our guide to genetic testing marketing, and school clinics in our guide to school-based health center marketing.

What NHLBI, MedlinePlus and HHS say

The National Heart, Lung, and Blood Institute (NHLBI) publishes the federal patient pages on sickle cell disease, MedlinePlus from the National Library of Medicine summarizes them, and the Department of Health and Human Services (HHS) explains who controls a minor’s health information. The points that shape a center’s marketing:

• Sickle cell disease is a group of inherited disorders that affect hemoglobin, and it is a lifelong illness that may be managed through preventive screening and treatment, according to the NHLBI page Sickle Cell Disease (last updated December 10, 2025). The page says treatment reduces or helps manage symptoms and increases longevity, and that with the right care people with the disease can live fulfilling lives.
• The NHLBI Symptoms page (last updated August 20, 2024) says symptoms vary from person to person and can change over time, that serious symptoms are emergencies that need treatment right away, and it lists them: severe pain, signs of serious anemia, fever above 101.3 degrees Fahrenheit (38.5 degrees Celsius), chest pain with coughing, fever and shortness of breath, stroke warning signs, and an erection that lasts 4 hours or more.
• The NHLBI Diagnosis page (last updated September 9, 2024) says all 50 states have newborn screening programs, that nearly all newborns in the United States are screened for sickle cell disease, and that a follow-up newborn screening team contacts the family directly if a child has the disease. The Causes and Risk Factors page (last updated August 20, 2024) describes the difference between inheriting one sickle cell gene and inheriting two.
• The NHLBI Living With page (last updated August 22, 2024) says the majority of people with the disease should see their provider every 3 to 12 months, depending on age and type, tells patients to set up a pain action plan with their provider ahead of time, and says that if pain cannot be managed at home a person can go to a sickle cell day hospital or clinic or to an emergency department. It says people with the disease report feeling that providers do not pay attention to their symptoms, and that stigma, bias and discrimination may affect medical care and make people delay getting care.
• The NHLBI Treatment page (last updated September 30, 2024) describes the care team, daily medicines, transfusions, pain care and complementary approaches that may lower pain for certain people. The MedlinePlus Sickle Cell Disease page (last updated September 6, 2024) lists the same range of treatments.
• The HHS guidance on personal representatives (content last reviewed January 5, 2024) says a parent is generally the personal representative of an unemancipated minor, names three circumstances in which the parent is not, and says the Privacy Rule defers to state or other law on a parent’s access to a minor’s information.

Two points shape the marketing. First, the serious symptoms are emergencies, so every page, message and tool a patient reaches must send them to emergency care before it offers an appointment. Second, a sickle cell center follows patients from infancy into adult life, and the people who sign forms, read portal messages and give permission change along the way. The copy, the forms and the reminders have to follow that change.

Describing the center and the care team

No federal page cited here defines what a “sickle cell center” or a “comprehensive” program must offer, so the words mean what the page shows. Name each service the center provides, who provides it and when: the hematology clinic, the day hospital for pain crises if there is one, transfusion services, the social worker, the psychologist, school and work letters, and the hospital the team admits to. If the center refers out for a service, say so and say where.

The NHLBI Living With page describes a sickle cell disease day hospital or clinic as a place to go when pain cannot be managed at home. If the center runs one, the page should say the days and hours it is open, how a patient gets there (a phone call first, or walk in), and what to do outside those hours. If the center has no day hospital, it should not imply one.

Phrases that need rewriting:

• “24/7 sickle cell crisis care.” Only if a clinician from the team can be reached at every hour. Otherwise say [days and hours] for the day hospital and the clinic, and give the emergency wording and 911 for every other time.
• “Comprehensive sickle cell center” with no detail. List the services and the staff roles, with [Clinician name, license] for each named clinician.
• “Skip the ER.” The NHLBI page names the emergency department as a place to get care when pain cannot be managed at home, and lists symptoms that need emergency care at once. Say what the day hospital does and when the emergency department is the right place.
• “The region’s leading sickle cell program.” A comparison claim needs evidence. Remove it, or state the fact it rests on and its source.

Emergency wording on every page and in every tool

Put the NHLBI emergency list on the sickle cell pages, above the booking button and the contact form. A short version a center can use, close to the NHLBI words: serious symptoms of sickle cell disease are emergencies and need treatment right away. Seek care or call 911 for severe pain, extreme tiredness with shortness of breath, dizziness or an irregular heartbeat, chest pain with coughing, fever and shortness of breath, or an erection lasting 4 hours or more. Call 911 for sudden weakness or numbness on one side of the body, confusion, or trouble speaking, seeing or walking. For a fever above 101.3 degrees Fahrenheit (38.5 degrees Celsius), get care from a healthcare provider right away. Link the NHLBI Symptoms page so readers can check it, and add the general line “If you think you are having a medical emergency, call 911.”

The same wording belongs on voicemail, after-hours messages, patient portal autoreplies, text replies, chat widgets and AI front desk tools. A message that says “my son has a fever” or “my pain is a 9” is not a scheduling request. The tool should give the emergency wording and the 911 line at once and alert staff, not judge the symptom or offer the next open slot. If the center has an on-call line for patients, give the number and say who answers it. Our guides to AI chatbots on practice websites and answering services and AI receptionists cover how those tools hand off urgent messages.

Phrases that need rewriting:

• “In pain? Request an appointment online.” Put the emergency wording first and the request form after it.
• “Message your care team about any symptoms.” Say who reads messages, during which hours, that the inbox is not watched around the clock, and give the emergency wording and 911.
• “Fever? Call us during business hours.” The NHLBI page says a fever above 101.3 degrees Fahrenheit needs attention from a healthcare provider right away. Give the on-call number or the emergency wording.

Writing about pain without stigma

The NHLBI Living With page says people with sickle cell disease report feeling that providers do not pay attention to their symptoms, and that stigma, bias and discrimination may lead them to delay care. A reader arrives with that history. The hematology guide covers respectful language in general. On a center’s pain pages, three more things matter: describe the pain plan, describe what happens when a patient arrives, and promise nothing about a prescription.

The NHLBI page tells patients to set up a pain action plan with their provider ahead of time. A center can explain how it builds that plan with each patient, who keeps a copy, and whether the team shares it with the emergency department the patient uses, with the patient’s permission. It can say how quickly a patient in the day hospital is seen if the center tracks that and can show it, and nothing beyond what it can show. It can describe the counseling and complementary approaches the NHLBI Treatment page lists as approaches that may lower pain, as additions to medical care, not replacements.

Phrases that need rewriting:

• “Get the pain medicine you need, fast.” A prescription promise. Describe the plan, the team and the day hospital hours, and say that clinicians decide treatment for each visit.
• “Opioid-free sickle cell care.” It implies a judgment about patients who need opioids, which the NHLBI Treatment page says a provider may prescribe for serious or long-lasting pain. Describe the full range of care instead.
• “No more pain crises.” The NHLBI page describes treatments that reduce or help manage symptoms. Remove it.
• “Drug seekers will not be served.” Never on a patient-facing page. Write clinic policies in neutral words and apply them to every patient.
• “Natural pain relief for sickle cell.” The NHLBI page says complementary approaches may lower pain for certain people, as part of care. Do not sell them as a substitute.

Treatment pages that stay current

Sickle cell treatment changes, and a page written once can fall out of date. The NHLBI Sickle Cell Disease page carries a notice that in September 2024 a medicine used to prevent sickling was withdrawn from the market by its maker, which said the benefits did not outweigh the risks in the approved sickle cell population. Any page or ad that had named that medicine as a reason to choose a clinic was wrong the day the notice went up.

Name no medicines in ads. On the treatment page, describe the categories the NHLBI Treatment page uses, such as daily medicines that can reduce sickling and pain crises, transfusions and pain care, link the NHLBI page and put a “last reviewed” date on the page with the name of the clinician who reviewed it. Set a review date, and review sooner when NHLBI or FDA posts a change. “Cure” and gene therapy wording follow the rules in the hematology guide, and transplant program pages follow the transplant guide.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. “Fewer hospital stays with our program” is a health benefit claim even if no number appears.

Phrases that need rewriting:

• “New sickle cell medicine available here” with a brand name. Name no product; say the team reviews treatment options with each patient.
• “Our patients spend fewer days in the hospital.” A results claim. Remove it unless the center has the data, the comparison and counsel’s review, and quote no number that is not sourced.
• “Gene therapy center.” Use the hematology guide’s wording and say whether the center provides the therapy or evaluates and refers.

Newborn screening, trait and family testing

The NHLBI Diagnosis page says nearly all newborns in the United States are screened, that a special follow-up team contacts families directly when a child has the disease, and that newborn screening also finds out whether a baby has sickle cell trait. A center that receives those referrals can write a page for new parents: what the follow-up call means, what the first visit covers, who the team is and how to reach it. Keep it calm and factual. The parent has just heard their baby needs more tests, and the NHLBI page says further testing confirms the result.

The NHLBI Symptoms page says people with sickle cell trait generally do not have symptoms of the disease and can pass the gene to their children, and the Diagnosis page says a blood test can show whether an adult has trait or disease. Trait testing at a community event or a family testing day can be useful. Keep trait and disease apart in every line, say what the test is and what happens with the result, and do not use fear to drive sign-ups. Our guides to health fair and screening event marketing and genetic testing marketing cover sign-in sheets, free offers and test results. “Free” offers follow 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere.

Teens moving to adult care: forms, consent and portal access

A center that sees both children and adults, or a pediatric program that hands patients to an adult partner, has a transition to plan and to describe. The marketing side of that is a page that tells families when planning starts, at [age], what the steps are and which adult team the patient moves to, plus forms, messages and portal settings that follow the patient as the rules change.

The HHS personal representatives guidance sets the frame. A parent is generally the personal representative of an unemancipated minor and controls the child’s health information. HHS names three exceptions: when state or other law does not require a parent’s consent for a particular service and the minor consents, when a court or other law lets someone other than the parent consent, and when a parent agrees to a confidential relationship between the minor and the provider. The Privacy Rule defers to state or other law on a parent’s access to a minor’s information. For an adult, the personal representative is a person with legal authority to make health care decisions for them, such as a health care power of attorney or a court-appointed guardian. The definitions sit in 45 CFR 164.502(g). The age of majority, minor consent and parent access are set state by state.

For a teen transition program, keep these points:

• Intake forms have a section the teen completes, and say plainly what the teen may discuss with the clinician in private and what the clinic shares with parents, in line with the state rules counsel confirms.
• Portal proxy access for parents is reviewed when the patient reaches adulthood under state law, and earlier if a confidential relationship applies. The page says when that change happens and how the young adult can give a parent access again if they choose.
• Reminder texts and emails go to the number the patient chooses once they are an adult, and say no diagnosis in the message text.
• A story, photo or video a parent authorized while the patient was a minor gets a fresh decision from the young adult before it is used again.
• School and work letters, and the teacher information the NHLBI Living With page recommends, are shared with the permission of the person who controls the information at that time.
• Event and education invitations for teens say who is running them, who is paying, and whether parents are invited.

Our guides to patient portal messages, text message appointment reminders and patient photo consent cover each of those in more detail.

Referrals, drug maker support and community groups

Sickle cell care draws partners: emergency departments, children’s hospitals, community organizations, school nurses, drug makers with patient support programs and research sponsors. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Where a center bills Medicare or Medicaid, the statute reaches every partnership on this list. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For a sickle cell center, keep these points:

• Do not give gifts, meals, free services or payments to emergency departments, community groups, school staff or other referral sources in return for patients without counsel’s review.
• Grants, event funding, staff, nurse educators, meals, speaker fees or materials from a drug maker go to counsel before any agreement is signed. Payments to physicians may be reported publicly; our guide to Open Payments covers that.
• A drug maker’s patient support or copay program is the maker’s program. Do not present it as the center’s own, and do not route patients to it as a condition of care.
• Community events and family days say who is paying, and a sponsor does not choose the speakers or the treatments discussed.
• Patients are not paid or given gifts for choosing the center or for bringing family members in for testing.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A visit to a sickle cell page, a booking at a hematology clinic or a family testing sign-up says something about a person’s health. Keep bookings, intake answers, test results, newborn screening referrals and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it; the hematology guide covers the other sensitive category that applies here. Ads can target by place and by search terms, and should not be built from a list of patients with sickle cell disease or trait.

Under 45 CFR 164.501, a reminder about the practice’s own treatment for an individual, such as a clinic visit or a transfusion due, can fall outside the definition of marketing, while a message that promotes a third party’s product, such as a drug maker’s program, generally needs a signed authorization under 45 CFR 164.508. A message paid for by a drug maker needs counsel’s review before it goes out.

Patient stories

A young adult who describes moving from the children’s team to the adult team, or a parent who describes the first visit after a newborn screening call, can help a reader who is afraid of the same step. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “I have not been in the hospital since I joined” is a results claim. Keep stories to the experience of care and the team, and pair them with the NHLBI wording that symptoms vary from person to person.

Get a signed authorization under 45 CFR 164.508 where the practice is a covered entity, and consent for any photo or video. For a minor, the authorization comes from the person who controls the child’s information, and the young adult decides again at adulthood. Name no medicine, say if the patient received anything for taking part, and let the patient review the final version. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two sickle cell center pages

Illustration: a page reads “The region’s leading 24/7 sickle cell center. Skip the ER and get the pain medicine you need, fast. Ask about our newest named medicine. Our patients stay out of the hospital. In pain? Book online.” It makes a comparison claim with no evidence, promises a prescription and around-the-clock care it may not have, names a medicine that can be pulled from the market, makes a results claim and puts a booking link where the emergency wording belongs.

Illustration: a second page for the same practice reads “Serious symptoms of sickle cell disease are emergencies. Seek care or call 911 for severe pain, chest pain with fever and shortness of breath, or an erection lasting 4 hours or more. Call 911 for sudden weakness, numbness, confusion or trouble speaking, seeing or walking. For a fever above 101.3 degrees Fahrenheit, call our on-call line at [phone] right away. At [Practice name], [Clinician name, license] and the team build a pain action plan with each patient. Our day hospital is open [days and hours]. Teens start planning their move to adult care at [age]; see how forms and portal access change. Call [phone].” It puts the NHLBI emergency wording first, describes the team and the plan, and promises nothing it cannot show.

Checklist before a sickle cell campaign goes live

• NHLBI and MedlinePlus pages named and dated, with a “last reviewed” date and reviewer on the treatment page.
• NHLBI emergency list and the 911 line above any booking button, and in voicemail, portal replies, text replies, chat and AI front desk tools.
• Day hospital, clinic and on-call hours stated exactly; no 24/7 claim the center cannot meet.
• No prescription promises, no opioid-free framing and no “no more crises” claims; pain action plan and team described instead.
• No medicine names in ads; cure and gene therapy wording follows the hematology guide.
• Trait and disease kept apart; newborn follow-up page calm and factual; free events follow 16 CFR 251.1.
• Teen transition page with [age], steps and the adult team; teen sections on intake forms; portal proxy, reminder contacts and story authorizations reviewed at adulthood under state law.
• No gifts or payments to referral sources; drug maker funding, staff and programs reviewed by counsel before signing; sponsors named.
• Bookings, results and screening referrals stay out of pixels and ad audiences; targeting by place and search terms only.
• Stories have signed authorizations, name no medicine, make no results claim and carry a statement of what people can generally expect.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including hematology practices and community clinics that run sickle cell programs. For a sickle cell center, that means a site that quotes NHLBI as written, puts the emergency wording above the booking button, explains the pain action plan and the day hospital hours, and gives teens and parents a clear transition page, plus booking and event forms that keep diagnoses and test results off the web and away from tracking tools. Our front desk tools hand urgent messages to the emergency wording, the on-call line and the 911 line, and do not triage symptoms. We do not decide who needs treatment; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NHLBI: Sickle Cell Disease (last updated December 10, 2025)
• NHLBI: Sickle Cell Disease, Causes and Risk Factors (last updated August 20, 2024)
• NHLBI: Sickle Cell Disease, Symptoms (last updated August 20, 2024)
• NHLBI: Sickle Cell Disease, Diagnosis (last updated September 9, 2024)
• NHLBI: Sickle Cell Disease, Treatment (last updated September 30, 2024)
• NHLBI: Living With Sickle Cell Disease (last updated August 22, 2024)
• MedlinePlus: Sickle Cell Disease (last updated September 6, 2024)
• HHS: Personal Representatives (content last reviewed January 5, 2024)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.502: Uses and disclosures of protected health information: General rules
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing